Subretinal Gene Therapy for Neovascular AMD

Update: 2025-10-03

Description

We review the latest results from the Regenexbio sub retinal gene therapy program with Robert Avery MD, California Retina Consultants, Santa Barbara, CA

Comments

In Channel

Suprachoroidal Gene Therapy for Nonproliferative Diabetic Retinopathy

2025-12-1914:09

Optogenetics for Treating Inherited Retinal Degenerations

2025-12-1115:24

Untitled EpisodeArtificial Intelligence in the Management of Macular Disease

2025-12-0324:12

Stem Cell Therapy for Geographic Atrophy

2025-11-1926:15

Intravitreal Gene Therapy for Neovascular AMD

2025-11-1319:49

The TRUCKEE Study of Faricimab for Neovascular AMD

2025-11-0515:07

The VERONA Trial of a TKI for the Treatment of DME

2025-10-2909:46

Photobiomodulation for the Treatment of Dry AMD

2025-10-2413:41

8 mg Aflibercept in Diabetic Macular Edema

2025-10-0811:18

Subretinal Gene Therapy for Neovascular AMD

2025-10-0316:26

Does Pegcetacoplan Treatment Affect Dry Macular Degeneration?

2025-09-2509:01

Rapid Fluid Resolution with Aflibercept 8mg may be Associated with Extended Dosing Intervals in nAMD

2025-09-0820:58

The Good Days Dilemma - Support for Patient Co-Payments in Retinal Pharmacotherapy

2025-08-2812:43

Immediate vs Delayed Treatment of GA with Pegcetacoplan

2025-08-1917:33

Eyes with both Geographic Atrophy and Neovascular AMD: An IRIS Study

2024-07-1212:07

The Davio 2 Trial for Neovascular AMD

2024-05-3113:47

The GALE Extension Study

2024-05-1715:06

AXPAXLI for Diabetic Retinopathy

2024-05-0904:44

NSAIDS in the treatment of Central Serous Chorioretinopathy

2024-04-1814:22

EY-103 a novel Wnt Pathway Agonist for Treatment of DME and neovascular AMD

2024-04-0421:41

00:00

Subretinal Gene Therapy for Neovascular AMD

#box-pro-ellipsis-176730419810814{-webkit-line-clamp:2;}Subretinal Gene Therapy for Neovascular AMD

Subretinal Gene Therapy for Neovascular AMD

Retina Synthesis

Subretinal Gene Therapy for Neovascular AMD